FDA Inspection 1320574 — Bayer Healthcare Pharmaceuticals Inc.
The FDA completed an inspection of Bayer Healthcare Pharmaceuticals Inc. on Jul 15, 2026 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 15, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Whippany, NJ (United States)
Additional Details
Sponsor, Contract Research Organization